PATENT CLAIM ANALYSIS

Application Number: 16030506
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "150100"]

Abstract:
The disclosure relates to compositions, pharmaceutical compositions, vaccines, and methods of making and using the same. The compositions of the disclosure are useful to stimulate an antigen-specific immune response and, in some embodiments, a protective immune response in an animal after challenge to pathogens. The compositions of the disclosure are also useful for treatment and prevention of disease in a subject such as cancer.

Claim (Index 38):
The method of  claim 32 , wherein the catanionic surfactant vesicle is lyophilized.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.7561
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14295306', '10236557', '14703543', '15230736', '12679519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6888117707979998
- 35 USC 102 Novelty (BERT): 0.6487607295225121
- Combined Prediction Score: 0.684806666670451
- Mean Citation Score: 346.174708
- Max Citation Score: 865.42175
- Similarity Product: 550.2416515940428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test